Article

Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease.

INSERM ERM 0220, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75475 Paris Cedex 10, France.
Blood (Impact Factor: 9.78). 07/2004; 103(12):4681-4. DOI: 10.1182/blood-2003-05-1548
Source: PubMed

ABSTRACT In an experimental model we demonstrated that endothelial cells of all organs are targets of the alloimmune reaction. Here, in 68 digestive biopsies, we found endothelial lesions by immunohistochemistry and ultrastructure in patients with severe acute graft-versus-host disease (GVHD). In contrast, no such endothelial cell alterations were found either in patients without GVHD or in nongrafted controls. In the biopsies with severe GVHD lesions, ultrastructure showed rupture of the capillary basal membrane and extravased red blood cells. These pericapillary hemorrhages were highly correlated with GVHD severity. In a separate cohort of 39 patients who underwent an allogeneic transplantation after a nonmyeloablative conditioning, 8 patients had intestinal biopsies. Three of these latter patients had both severe pathologic lesions of GVHD and similar endothelial lesions, thus, strengthening the concept that endothelial lesions are linked to GVHD severity and not to the intensity of the conditioning regimen. (Blood. 2004;103:4681-4684)

0 Bookmarks
 · 
91 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Superselective arterial embolization is a common therapeutic procedure for cases of visceral hemorrhage. However, until now, it has not been applied in the treatment of gastrointestinal (GI) hemorrhage caused by acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation. We describe a case presenting with persistent GI bleeding associated with acute GVHD successfully treated by superselective arterial embolization of the superior mesenteric artery with gelatin sponge after noneffective conventional management. This case will help guide hematologists to deal with a similar situation in the future.
    Patient Preference and Adherence 01/2014; 8:1581-1585. · 1.49 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Steroid non-responsive acute graft-versus-host disease (aGvHD) following hematopoietic stem cell transplantation carries a poor prognosis. Various groups have reported beneficial effects of mesenchymal stromal cells (MSC) as salvage treatment. Response to treatment is typically evaluated using the diagnostic clinical criteria for aGvHD. In this study we report the usefulness of additional gastrointestinal biopsies paired with serum biomarkers. In a cohort of 22 pediatric patients, persistent or recurrent diarrhea was seen in 18 children treated with MSC for steroid refractory aGvHD. To exclude other causes of gastrointestinal pathology, patients were biopsied for histological analysis. In 8 out of 12 patients, residual tissue damage and villous atrophy, but no active aGvHD was seen. Serum biomarkers have been described as alternatives to monitor response to aGvHD treatment. The value of biomarkers for inflammation, tissue and endothelial cell damage was evaluated in our cohort. Although predictive for response to treatment and survival, we demonstrate that these markers lack the required specificity and sensitivity to predict response to MSC therapy. Objective end-points for clinical trials on the treatment of steroid refractory aGvHD have yet to be defined. We therefore recommend that biopsies and biomarkers are included to discriminate between ongoing aGvHD and post inflammatory malabsorption.
    Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation 08/2013; · 3.15 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: There is accumulating evidence indicating that endothelial factors are involved in the pathogenesis of GVHD. We have recently shown that steroid-refractory, but not sensitive, GVHD is characterized by higher pretransplantation serum levels of angiopoetin-2 (ANG2), a hormone mediating endothelial vulnerability. To evaluate whether endothelial vulnerability is a risk factor for GVHD per se or becomes important only when noticeable GVHD is established, we measured ANG2 along with additional serum markers of endothelial stress, including soluble thrombomodulin (sTM), IL-8 (CXCL8), and hepatocyte growth factor (HGF), in patients with no, low-grade, or severe GVHD. Patients with refractory GVHD exhibited elevated serum levels of ANG2, sTM, HGF, and IL-8 posttransplantation compared with patients with sensitive GVHD and patients without GVHD. Pretransplantation ANG2 was the only growth factor correlated with the risk of refractoriness and mortality, and then only within the subset of patients who developed grade III-IV GVHD. In contrast, ANG2 was not predictive of GVHD or nonrelapse mortality (NRM) in patients with no GVHD or low-grade GVHD. These findings provide evidence that endothelial function plays an important role in the pathogenesis of steroid refractoriness in ongoing GVHD; however, endothelial vulnerability does not predict incidence of GVHD.
    Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation 01/2013; 19(1):22–27. · 3.15 Impact Factor

Full-text (2 Sources)

Download
51 Downloads
Available from
May 30, 2014